Cybin Inc. Common Shares CYBN 深 沪
等待开盘 08-16 09:30:00 美东时间
7.06
-0.110
-1.53%
华盛通- 最 高7.23
- 今 开7.16
- 成交量 43.09万股
- 最 低 6.99
- 昨 收 7.17
- 总市值 1.63亿
- 52周最高 13.88
- 市盈率 静 --
- 换手率 1.87%
- 52周最低 4.81
- 委 比 60.00%
- 总股本 2302.36万
- 历史最高 122.36
- 量 比 1.27
- 振 幅 3.35%
- 历史最低 4.81
- 每 手 1
- 风险率 3.30%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Cybin reports Q1 results
Cybin press release (NYSE:CYBN): Q1 cash totaled $118.7 million as of June 30, 2025. Net loss was $24.6 million for the quarter ended June 30, 2025, compared to a net loss of $10.8 million in the same...
08-14 15:30
Cybin's Clinical Trial Application Approved By Irish Medicines Board To Initiate EMBRACE Study In Ireland, Poland, And Greece
- EMBRACE, the second study within the Phase 3 PARADIGM program, will enroll 330 participants at approximately 60 clinical sites across the United States, Europe, the United Kingdom, and Australia -- European CTA
08-07 19:42
精神健康成医药并购新风口！传艾伯维(ABBV.US)正洽谈收购Gilgamesh 估值或达10亿美元
据知情人士透露，艾伯维正在洽谈收购专注于精神健康治疗的Gilgamesh Pharmaceuticals。如果交易成功，将增强艾伯维在精神疾病治疗方面的产品管线。
07-31 08:52
Cybin Secures UK Approval for Pivotal Depression Study
An announcement from Cybin ( ($TSE:CYBN) ) is now available. Cybin has received...
07-17 20:10
Reported Earlier: 'The key to living longer could be tied to a surprising substance, study suggests'- Fox News
https://www.foxnews.com/health/key-living-longer-could-tied-surprising-substance-study-suggests
07-16 22:45
Cybin Inc. Expands Market Strategy with New SEC Filing
Cybin ( ($TSE:CYBN) ) just unveiled an update. On July 14, 2025, Cybin Inc. fil...
07-15 05:47
Canaccord Genuity Maintains Buy on Cybin, Lowers Price Target to $70
Canaccord Genuity analyst Sumant Kulkarni maintains Cybin (AMEX:CYBN) with a Buy and lowers the price target from $73 to $70.
07-09 01:27
Cybin Inc. Reports on Governance and Compliance
Cybin, Inc. ( ($CYBN) ) has released its Q4 earnings. Here is a breakdown of th...
07-08 11:50
Cybin reports Q4 results
Cybin press release (NYSE:CYBN): Q4 Cash totaled C$135 million as of March 31, 2025. Net loss was C$31 million for the quarter ended March 31, 2025, compared to a net loss of C$21 million in the same ...
07-01 14:23
'Colorado Moves to Allow Hallucinogen Ibogaine for Medical Use'- Bloomberg
https://www.bloomberg.com/news/articles/2025-06-30/colorado-moves-to-allow-hallucinogen-ibogaine-for-medical-use?embedded-checkout=true
06-30 23:58
